Genomic characterization and immunotherapy for microsatellite instability-high in cholangiocarcinoma
Xu Yang,Baofeng Lian,Nan Zhang,Junyu Long,Yiran Li,Jingnan Xue,Xiangqi Chen,Yunchao Wang,Yanyu Wang,Ziyu Xun,Mingjian Piao,Chenpei Zhu,Shanshan Wang,Huishan Sun,Zhijian Song,Leilei Lu,Xiaowei Dong,Aodi Wang,Wenjin Liu,Jie Pan,Xiaorong Hou,Mei Guan,Li Huo,Jie Shi,Haohai Zhang,Jinxue Zhou,Zhenhui Lu,Yilei Mao,Xinting Sang,Liqun Wu,Xiaobo Yang,Kai Wang,Haitao Zhao
DOI: https://doi.org/10.1186/s12916-024-03257-7
IF: 9.3
2024-01-31
BMC Medicine
Abstract:Microsatellite instability-high (MSI-H) is a unique genomic status in many cancers. However, its role in the genomic features and immunotherapy in cholangiocarcinoma (CCA) is unclear. This study aimed to systematically investigate the genomic characterization and immunotherapy efficacy of MSI-H patients with CCA.
medicine, general & internal